Share This
Create Your Own Business Intelligence Website
Input the stock code or the company name     Search  

<002424.CN> - Guizhou Bailing Group Pharmaceutical Co., Ltd.

 
 Basic Datum
Company name 资产收益 每股收益 每股资产 收入增长 利润增长
GZBL 2.94% 0.12 4.19 29.88% 15.22%
 
Company name 价位 五日表现 五日换手 十日表现 十日换手
GZBL 8.35 1.91% 33.27% 2.32% 53.84%
 
所属板块: 医药 生物医药
 
 
 Related news  
證券時報網訊,4月29日晚間,貴州百靈(002424)(002424)發布2023年年報,報告期內,該公司全年實現營業收入42.63億元,創歷史新高,同比增長20.42%;實現淨利潤為-4.15億元,同比由盈轉虧。 業內人士指出,貴州百靈業績波動是行業因素及公司自身戰略調整引發的短期陣痛,直營模式的改革有利於上市公司長遠發展,跟隨宏觀經濟復蘇打開新一輪增長空間
≫More
 
 
 
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
GZBL 05-13 15:00 8.35  0.03  0.36%
≫More
 
 
More Topics:
| Real Est HKConstructionReal Est ChinaRentals | REITs
AgriEnviro | fertilizer producersWater | Util
HK Banks | China Banks | Insure | China Finance | Brokers
Consumer | Food | SupermarketDiaryEducation
merchant | Garment | HK Apparel | Sports
Appl | Auto | jewel | Beauty | HK retail
Shipping | Shipbuilding | Harbour | Highways | Airlines | logistics | Expo | Textile
Paper | Resource | Rare Earths | Steel | Gold mine | Mach
Petro | Electricity | Nuclear power | New Energy | gas | coal
Infra | Railway | Build Mat | Cement
China IT | Communication
GamblingChina LotterymediafilmDrugs
  HK Housing Market | Real Estate Market | | |
| | | HK Stock | Stock Trend | capital flow |
A Shares | ETF | IPO | |
Gold | Gold Jew | Oil | Commodity | G20 | Top 500
USD | GBD | EURO | Swiss franc | AUD | NZD | CAD | YEN | RMB | Korean Won | Taiwan Dollar (TWD)
iBond | Emerging markets
Lang | Andy Xie | Simon Ting | Law Ka-Chung | LiuDongliang | XieXuren | FanGang | Mobius | BillGross | Roubini | Faber
Financial and political policy | Central Bank Monetary Policy | Social Security Fund
| | | |

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.